On September 15, 2021 Cellectar Biosciences, Inc. (NASDAQ: CLRB), a late-stage clinical biopharmaceutical company focused on the discovery and development of drugs for the treatment of cancer, reported that James Caruso, president and CEO, will present a company overview at the following upcoming conference (Press release, Cellectar Biosciences, SEP 15, 2021, View Source [SID1234587734]):

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Oppenheimer Fall Healthcare Life Sciences & MedTech Summit

Presentation Date: Monday, September 20, 2021
Presentation Time: 12:25PM Eastern Time
Webcast Link: View Source

A replay of the presentation will be available on the Events Page of the company’s website (www.cellectar.com).